Citations are updated once a week. Recently added citations may not appear.
| Context | Citation |
|---|---|
| Psoriasis |
📓
Dysbiosis of gut microbiota and its correlation with dysregulation of cytokines in psoriasis patients. BMC microbiology (BMC Microbiol ) Vol: 21 Issue 1 Pages: 78 Pub: 2021 Mar 8 Epub: 2021 Mar 8 Authors Zhang X , Shi L , Sun T , Guo K , Geng S , Html Article Publication |
| Psoriasis |
📓
Psoriasis Is Associated With Elevated Gut IL-1a and Intestinal Microbiome Alterations. Frontiers in immunology (Front Immunol ) Vol: 11 Issue Pages: 571319 Pub: 2020 Epub: 2020 Oct 1 Authors Yegorov S , Babenko D , Kozhakhmetov S , Akhmaltdinova L , Kadyrova I , Nurgozhina A , Nurgaziyev M , Good SV , Hortelano GH , Yermekbayeva B , Kushugulova A , Html Article Publication |
| Psoriasis |
📓
Metagenomic analysis of gut microbiota in non-treated plaque psoriasis patients stratified by disease severity: development of a new Psoriasis-Microbiome Index. Scientific reports (Sci Rep ) Vol: 10 Issue 1 Pages: 12754 Pub: 2020 Jul 29 Epub: 2020 Jul 29 Authors Dei-Cas I , Giliberto F , Luce L , Dopazo H , Penas-Steinhardt A , Html Article Publication |
| Psoriasis |
📓
Gut microbial composition in patients with psoriasis. Scientific reports (Sci Rep ) Vol: 8 Issue 1 Pages: 3812 Pub: 2018 Feb 28 Epub: 2018 Feb 28 Authors Codoñer FM , Ramírez-Bosca A , Climent E , Carrión-Gutierrez M , Guerrero M , Pérez-Orquín JM , Horga de la Parte J , Genovés S , Ramón D , Navarro-López V , Chenoll E , Html Article Publication |
| Psoriasis |
📓
Decreased bacterial diversity characterizes the altered gut microbiota in patients with psoriatic arthritis, resembling dysbiosis in inflammatory bowel disease. Arthritis & rheumatology (Hoboken, N.J.) (Arthritis Rheumatol ) Vol: 67 Issue 1 Pages: 128-39 Pub: 2015 Jan Epub: Authors Scher JU , Ubeda C , Artacho A , Attur M , Isaac S , Reddy SM , Marmon S , Neimann A , Brusca S , Patel T , Manasson J , Pamer EG , Littman DR , Abramson SB , Html Article Publication |
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
